INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 5.02 billion | 5.5% | North America |
| By Product | By Type | By Application |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Antimicrobial Susceptibility Testing Market Overview
The global antimicrobial susceptibility test market is projected to reach USD 5.02 billion by 2029 from USD 3.10 billion in 2022, at a CAGR of 5.5% from 2023 to 2029.
The antimicrobial susceptibility test is a laboratory test used by qualified laboratory scientists and medical technologists to determine whether a patient’s antimicrobial regimen is effective. The basic goal of the Antimicrobial Susceptibility Test is to determine whether or not antibiotic medicine will work. To guarantee that the results can be repeated, these tests are carried out under controlled conditions. The results of this test help doctors choose the optimal antibiotic for the patient. Regular antibiotic susceptibility testing is performed to ensure that antibiotics are utilised effectively. It determines the lowest concentrations of new or existing antimicrobial medicines that prohibit consistent and detectable growth of the bacterium under research in certain test circumstances. It entails finding drug resistance in some of the most common diseases as well as determining the susceptibility of preferred treatments for certain infections.
| ATTRIBUTE | DETAILS |
| Study period | 2022-2029 |
| Base year | 2022 |
| Estimated year | 2023 |
| Forecasted year | 2023-2029 |
| Historical period | 2018-2021 |
| Unit | Value (USD Billion) |
| Segmentation | By Product, By Method, By Type, By Application, By End User, By Region. |
| By Product |
|
| By Method |
|
| By Type |
|
| By Application |
|
| By Region |
|
The development of a new broad spectrum of antibacterial medications is required as the prevalence of infectious diseases rises. Governments all over the world are investing extensively in research and development for antimicrobial susceptibility test kits that generate faster results, and private firms are doing the same, which is projected to drive the antimicrobial susceptibility test market forward. Rapid test methods are emerging as a result of technological advancements in medical research, leading to the overall growth of the antimicrobial susceptibility test market over the forecast period.
This lowers the cost of antibacterial medications for pharmaceutical corporations. This lack of return on investment is hampering the worldwide market’s expansion. Antimicrobial research and development, on the other hand, takes longer and necessitates more resources and specialised methodologies. In addition, an unfavorable reimbursement scenario and a low return on investment are impeding the growth of the Antimicrobial Susceptibility Test Market. On the other hand, the high cost of these systems is a key barrier to their widespread adoption by end-users, particularly small-budget organisations.
Antimicrobial susceptibility test kits are in high demand due to infectious organisms such as haemophilus influenzae, neisseria meningitides, streptococcus pneumoniae, shigella, vibrio cholerae, neisseria gonorrhoeae, and salmonella serotype typhi. The automated antimicrobial susceptibility test devices come with a variety of modern features and functions, and they’re reasonably priced. When using automated Antimicrobial Susceptibility Test techniques, the incubation and detection times are cut in half. Antimicrobial medications, unlike other therapies for chronic illnesses that are used for the remainder of the patient’s life, are only used for a brief time to cure the patients.
Antimicrobial Susceptibility Testing Market Segment Analysis
The antimicrobial susceptibility test market is divided into automated laboratory instruments, susceptibility testing disks, manual antimicrobial susceptibility test products, MIC strips, susceptibility plates, culture and growth media, consumables based on products. Manual susceptibility testing products have dominated the antimicrobial susceptibility test market. The market is expected to grow as antimicrobial resistance develops, new products are released, and susceptibility testing equipment gain traction in emerging markets.
The market is divided into dilution, disk diffusion, ETEST, automated antimicrobial susceptibility test, genotypic method based on method. Among these approaches, the automated antimicrobial susceptibility test equipment sector had the biggest market share. The majority of the segment’s revenue comes from its speed, precision, and capacity to deliver qualitative and quantitative susceptibility data. In addition, the segment’s expansion is being fueled by technological advancements and increased R&D efforts by key rivals to provide innovative solutions to the market.
The market is divided into antibacterial testing, antifungal testing, and ant parasitic testing based on type. Among these, antibacterial susceptibility testing has the largest proportion of the market. The bulk of cases in this group are due to the abuse of broad-spectrum antibiotics and the emergence of multidrug resistance. Drug resistance develops in microorganisms as a result of the overuse of broad-spectrum antibiotics, prompting the need for better drug screening.
The market is divided into clinical diagnostics, drug discovery and development, epidemiology based on application. The clinical diagnostics segment commanded the most market share. The rising prevalence of infectious diseases, the rising incidence of HAIs, the large target patient population base (especially in emerging countries), the growing procedural volume of clinical diagnostic tests, the growing emphasis on effective and early disease diagnosis across major markets, and the introduction of various technologically advanced susceptibility testing products all contribute to this segment’s large share.
The market is divided into diagnostic centers and hospitals, pharmaceutical and biotechnology companies, contract research organizations (CROS), research and academic institutes based on end user. Antifungal test procedure done in diagnostic laboratories and hospital, and also increase in the number of hospitals in significant market. Advances in healthcare infrastructure are expected to have an impact on the antibiotic susceptibility testing sector. The installation and use of more advanced, efficient, and sophisticated antibiotic susceptibility testing equipment and procedures at healthcare facilities all over the world has been made possible by government investment on healthcare.
Antimicrobial Susceptibility Testing Market Players
The major players operating in the global antimicrobial susceptibility test industry include BioMérieux, BD, Danaher, Thermo Fisher, Bio-Rad, Hi-Media, MERLIN, Liofilchem, Accelerate, and Alifax. The presence of established industry players and is characterized by mergers and acquisitions, joint ventures, capacity expansions, substantial distribution, and branding decisions to improve market share and regional presence. Also, they are involved in continuous R&D activities to develop new products as well as are focused on expanding the product portfolio. This is expected to intensify competition and pose a potential threat to the new players entering the market.
- In 2020, Liofilchem received the US FDA approval for its Lefamulin 0.016-256 μg/mL MTS (MIC Test Strip). It is a quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of lefamulin.
Who Should Buy? Or Key Stakeholders
- Research and development
- Manufacturing
- Diagnostic Centers and Hospitals
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Research and Academic Institutes
- Healthcare sector
- Specialty Clinic
- Others
Antimicrobial Susceptibility Testing Market Regional Analysis
Geographically, the antimicrobial susceptibility test market is segmented into North America, South America, Europe, APAC and MEA.
- North America: includes the US, Canada, Mexico
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
North America is expected to hold the largest share of the global antimicrobial susceptibility test market. Â The key drivers driving market growth in North America include increased R&D to develop novel automated AST systems, rising prevalence of infectious diseases, safety concerns, and technological developments in antimicrobial susceptibility products. Furthermore, most of the world’s leading firms, including as Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, and Bruker Corporation, are located in the region or have a significant presence there. Others have concentrated on growth in order to broaden their reach and skills. Another important factor contributing to the market’s rapid expansion is this.
Key Market Segments: Antimicrobial Susceptibility Testing Market
Antimicrobial Susceptibility Testing Market by Product, 2022-2029, (USD Million)
- Automated Laboratory Instruments
- Susceptibility Testing Disks
- Manual Antimicrobial Susceptibility Test Products
- Mic Strips
- Susceptibility Plates
- Culture and Growth Media
- Consumables
Antimicrobial Susceptibility Testing Market by Method, 2022-2029, (USD Million)
- Dilution
- Disk Diffusion
- ETEST
- Automated Antimicrobial Susceptibility Test
- Genotypic Method
Antimicrobial Susceptibility Testing Market by Type, 2022-2029, (USD Million)
- Antibacterial Testing
- Antifungal Testing
- Ant Parasitic Testing
Antimicrobial Susceptibility Testing Market by Application, 2022-2029, (USD Million)
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
Antimicrobial Susceptibility Testing Market by End User, 2022-2029, (USD Million)
- Diagnostic Centers and Hospitals
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (Cros)
- Research and Academic Institutes
Antimicrobial Susceptibility Testing Market by Regions, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Antimicrobial Susceptibility Testing Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global Antimicrobial Susceptibility Testing Market
- Global Antimicrobial Susceptibility Testing Market Outlook
- Global Antimicrobial Susceptibility Testing Market by Product, (USD Million)
- Automated Laboratory Instruments
- Susceptibility Testing Disks
- Manual Antimicrobial Susceptibility Test Products
- MIC strips
- Susceptibility Plates
- Culture and Growth Media
- Consumables
- Global Antimicrobial Susceptibility Testing Market by Method, (USD Million)
- Dilution
- Disk Diffusion
- ETEST
- Automated Antimicrobial Susceptibility Test
- Genotypic Method
- Global Antimicrobial Susceptibility Testing Market by Type, (USD Million)
- Antibacterial Testing
- Antifungal Testing
- Ant Parasitic Testing
- Global Antimicrobial Susceptibility Testing Market by Application, (USD Million)
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
- Global Antimicrobial Susceptibility Testing Market by End Users, (USD Million)
- Diagnostic Centers and Hospitals
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Research and Academic Institutes
- Global Antimicrobial Susceptibility Testing Market by Region, (USD Million)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle-East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle-East and Africa
- Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
-
-
- BioMérieux
- Danaher
- Thermo Fisher
- Bio-Rad
- Hi-Media
- MERLIN
- Liofilchem
- Accelerate
- Alifax
- Others *The Company List Is Indicative
-
LIST OF TABLES
TABLE 1 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS)
TABLE 2 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 3 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 4 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 5 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 6 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 7 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 8 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 9 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â US ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â US ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â UK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â UK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â UK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â UK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â UK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â Â Â SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â Â Â RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â Â Â RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â Â Â RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â Â Â RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â Â Â RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 111Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 112Â Â Â Â Â Â Â Â Â Â Â UAE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 113Â Â Â Â Â Â Â Â Â Â Â UAE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 114Â Â Â Â Â Â Â Â Â Â Â UAE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 115Â Â Â Â Â Â Â Â Â Â Â UAE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 116Â Â Â Â Â Â Â Â Â Â Â UAE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 117Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 118Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 119Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 120Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 121Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 122Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 123Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 124Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 125Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 126Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
TABLE 127Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 128Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 129Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 130Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 131Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER USD MILLION, 2020-2029
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 14          PORTER’S FIVE FORCES MODEL
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY PRODUCT, USD MILLION, 2020-2029
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY METHOD, USD MILLION, 2020-2029
FIGURE 17Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY TYPE, USD MILLION, 2020-2029
FIGURE 18Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 19Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY END USER USD MILLION, 2020-2029
FIGURE 20Â Â Â Â Â Â Â Â Â Â GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 21Â Â Â Â Â Â Â Â Â Â ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET BY REGION 2020
FIGURE 22Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 23          BIOMÉRIEUX: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â DANAHER: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â THERMO FISHER: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â BIO-RAD: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â HI-MEDIA: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â MERLIN: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â LIOFILCHEM: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â Â Â Â Â Â Â ACCELERATE: COMPANY SNAPSHOT
FIGURE 31Â Â Â Â Â Â Â Â Â Â ALIFAX: COMPANY SNAPSHOT
FAQ
The antimicrobial susceptibility testing market size had crossed USD 3.10 Billion in 2020 and will observe a CAGR of more than 5.5% up to 2029 driven by the rising incidence of infectious diseases coupled with epidemic & pandemic events.
The upcoming trend in antimicrobial susceptibility testing market is awareness initiatives for antimicrobial resistance and its control is an opportunity for market growth.
The global antimicrobial susceptibility testing market registered a CAGR of 5.5% from 2022 to 2029. The method segment was the highest revenue contributor to the market.
Clinical diagnostics segment is dominating the antimicrobial susceptibility testing market.
North America is the largest regional markets with 48% of share increased R&D to develop novel automated AST systems, rising prevalence of infectious diseases, safety concerns, and technological developments in antimicrobial susceptibility products.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.